High Purity Pharmaceutical Intermediates Voriconazole Powder CAS 137234-62-9

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Frazer-Voriconazole
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: White Powder
• Purity: >99%
• CAS No.: 137234-62-9
• Colour: White
• Appearance: White Powder
• Shelf Life: 2 Years
• Storage: Store in a Well-Closed Container Away From Moistur
• Form: Powder
• Delivery: Express 5-7 Days Arrive
• Test Method: HPLC
• Assay: 98%
• Storage Temp.: Store at +4°c
• Melting Point: 127-130°c
• Grade: Pharmaceutical Grade
• Transport Package: Foil Bag
• Specification: 1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 1000kg/Month

Product Description

High Purity Pharmaceutical Intermediates Voriconazole Powder CAS137234-62-9

 

Specification of Analysis

Items	Standards
Appearance	White or off-white crystalline powder
Identification	By IR
	By HPLC
Solubility	Very slightly soluble in water
Water Content	≤ 4.00%
Heavy Metals	≤ 10ppm
Residue on Ignition	≤ 0.10%
Optical Isomer	≤ 0.50%
Related Substances	Impurity B: ≤0.20%
	Impurity C: ≤0.20%
	Impurity D: ≤0.10%
	Impurity F: ≤0.10%
	Any unspecified impurity: ≤0.10%
	Total Impurities: ≤0.50%
Purity(HPLC)	≥99.0%
Assay                  (on the anhydrous basis)	97.5%~102.0%

 

Product Description

Voriconazole is a broad-spectrum triazole antifungal ,it is primarily used for the treatment of progressive, possibly life-threatening infections in immune deficiency patients. Indications include: immunosuppressed patients with severe fungal infections, acute invasive aspergillosis (the most common pathogen is Aspergillus fumigatus, followed by A. flavus, Aspergillus niger and Aspergillus soil), severe invasive infections caused by fluconazole-resistant Candida (including C. krusei) severe infection caused by Foot actinomycetes bacteria genu.

Application & Function of Voriconazole

a. Voriconazole is a triazole antifungal medication, it can cure empirical antifungal therapy.
b. Voriconazole has become the new standard of care in the treatment of invasive aspergillosis.
c. Voriconazole can be used in the treat of esophageal candidiasis.
d. Voriconazole has also been used to treat severe fungal corneal infection.
e. An antifungal (systemic). An ergosterol biosynthesis inhibitor.